A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Metastatic Cancer
Related studies linked through entity extraction aliases.
Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
- Status
- RECRUITING
- Phase
- PHASE2
Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib in Tumors Metastatic to the CNS
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Dose Efficiency of Modern CT Scanners in Oncologic Scans
- Status
- UNKNOWN
- Phase
- NA
Patient Reported Outcomes/Metrics Program Trial
- Status
- RECRUITING
- Phase
- N/A
Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
- Status
- TERMINATED
- Phase
- PHASE1
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
- Status
- WITHDRAWN
- Phase
- PHASE2
Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
- Status
- COMPLETED
- Phase
- N/A
Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
- Status
- UNKNOWN
- Phase
- N/A
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial
- Status
- COMPLETED
- Phase
- N/A
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2